We have all been guilty of the \"revenge bedtime procrastination\"—scrolling through reels at 1 AM, convinced that slapping ...
Researchers have engineered a therapy that moves through the bloodstream, enters the brain, and begins fixing the damage left ...
New research highlights the importance of timing in skincare, introducing Circadian Skincare. This approach aligns product application with the skin's natural 24-hour rhythm, which shifts between ...
New nanomaterial passes the blood-brain barrier to reduce damaging inflammation after the most common form of stroke. When ...
The MarketWatch News Department was not involved in the creation of this content. -- PEGASUS(TM) is an industry-first in peptide design: It achieves AI-driven generative design of the first permeable ...
A four–amino acid peptide called CAQK has shown powerful brain-protective effects in animal models of traumatic brain injury. Delivered through a standard IV, it zeroes in on injured brain tissue, ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
The continued approval of Forzinity is contingent upon verification and description of clinical benefit in a confirmatory trial. The Food and Drug Administration (FDA) has granted accelerated approval ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Preventing the aggregation of α-synuclein (αS) into toxic oligomers and conformers is ...
The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for elamipretide in the treatment of Barth syndrome, a rare mitochondrial disease.